The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice
Day, Emily A, Ford, Rebecca J, Lu, Jessie H, Lu, Rachel, Lundenberg, Lucie, Desjardins, Eric M, Green, Alex E, Lally, James S V, Schertzer, Jonathan D, Steinberg, Gregory R
Published in Biochemical journal (26.06.2020)
Published in Biochemical journal (26.06.2020)
Get more information
Journal Article
Macrophage AMPK β1 activation by PF-06409577 reduces the inflammatory response, cholesterol synthesis, and atherosclerosis in mice
Day, Emily A., Townsend, Logan K., Rehal, Sonia, Batchuluun, Battsetseg, Wang, Dongdong, Morrow, Marisa R., Lu, Rachel, Lundenberg, Lucie, Lu, Jessie H., Desjardins, Eric M., Smith, Tyler K.T., Raphenya, Amogelang R., McArthur, Andrew G., Fullerton, Morgan D., Steinberg, Gregory R.
Published in iScience (17.11.2023)
Published in iScience (17.11.2023)
Get full text
Journal Article
Canagliflozin Directly Reduces Macrophage Inflammation via AMPK in a Mouse Model of Atherosclerosis
Day, Emily A., Ford, Rebecca J., Lu, Jessie H., Lu, Rachel, Lally, James S., Schertzer, Jonathon D., Steinberg, Gregory R.
Published in Atherosclerosis. Supplements (01.06.2018)
Published in Atherosclerosis. Supplements (01.06.2018)
Get full text
Journal Article